Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Quantum-Si IncQSI · Entity 6440 | Chief Commercial Officer | September 22, 2025 | September 24, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Quantum-Si Inc
Report date September 22, 2025 · Filed September 24, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 681,521 |
Ending reported balance
After 2025-09-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-09-22 · Sale · Disposed 18,482 · Balance 700,003 F1: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.64 to $1.72 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Row 2 · 2025-09-23 · Sale · Disposed 18,482 · Balance 681,521 F1: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.57 to $1.79 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award.
F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.64 to $1.72 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.57 to $1.79 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LUMINEX CORP
Report date July 14, 2021 · Filed July 15, 2021
Section 16 reporting ended · disclosed 2021-07-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2021-07-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-07-14 · Disposition to issuer · Disposed 17,342 · Balance 30,266 F1: Disposed of pursuant to the Agreement and Plan of Merger, by and among DiaSorin S.p.A., Diagonal Subsidiary Inc. and Luminex Corporation (the "Issuer"), dated April 11, 2021 (the "Merger Agreement"), whereby each outstanding share of the Issuer's common stock was cancelled at the effective time (the "Effective Time") of the merger (the "Merger") and converted into the right to receive a cash payment of $37.00 per share. F2: This balance includes 29 shares obtained under the Luminex Corporation Employee Stock Purchase Plan on May 31, 2021. Row 2 · 2021-07-14 · Disposition to issuer · Disposed 30,266 · Balance 0 F3: Disposed of pursuant to the Merger Agreement, whereby unvested shares of restricted stock which were outstanding as of immediately prior to the Effective Time fully vested and became unrestricted common stock, and each such share of common stock that was outstanding immediately prior to the Effective Time was canceled at the Effective Time, in exchange for cash payments in the amount of $37.00 per share (without interest and subject to deduction for any required withholding taxes). |
| Stock Option (Right To Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.04 · Expires 2024-03-10 | Direct | 0 |
Reported balance
After 2021-07-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-07-14 · Disposition to issuer · Disposed 14,652 · Balance 0 F4: Disposed of pursuant to the Merger Agreement, whereby each stock option outstanding as of immediately prior to the Effective Time fully vested and was cancelled at the Effective Time and converted into the right to receive a total amount in cash, equal to the product of (x) the excess, if any, of $37.00 over the exercise price per share of each stock option (without interest and subject to deduction for any required withholding taxes) and (y) the number of shares underlying such stock option. If the amount that could have been obtained upon the exercise of the stock option pursuant to the foregoing is equal to or less than zero, then the option was terminated without payment. |
| Stock Option (Right To Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.98 · Expires 2025-03-12 | Direct | 0 |
Reported balance
After 2021-07-14 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-07-14 · Disposition to issuer · Disposed 12,849 · Balance 0 F4: Disposed of pursuant to the Merger Agreement, whereby each stock option outstanding as of immediately prior to the Effective Time fully vested and was cancelled at the Effective Time and converted into the right to receive a total amount in cash, equal to the product of (x) the excess, if any, of $37.00 over the exercise price per share of each stock option (without interest and subject to deduction for any required withholding taxes) and (y) the number of shares underlying such stock option. If the amount that could have been obtained upon the exercise of the stock option pursuant to the foregoing is equal to or less than zero, then the option was terminated without payment. |
| Stock Option (Right To Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.43 · Expires 2026-03-12 | Direct | 0 |
Reported balance
After 2021-07-14 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-07-14 · Disposition to issuer · Disposed 16,191 · Balance 0 F4: Disposed of pursuant to the Merger Agreement, whereby each stock option outstanding as of immediately prior to the Effective Time fully vested and was cancelled at the Effective Time and converted into the right to receive a total amount in cash, equal to the product of (x) the excess, if any, of $37.00 over the exercise price per share of each stock option (without interest and subject to deduction for any required withholding taxes) and (y) the number of shares underlying such stock option. If the amount that could have been obtained upon the exercise of the stock option pursuant to the foregoing is equal to or less than zero, then the option was terminated without payment. |
| Stock Option (Right To Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.09 · Expires 2027-03-12 | Direct | 0 |
Reported balance
After 2021-07-14 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-07-14 · Disposition to issuer · Disposed 72,976 · Balance 0 F4: Disposed of pursuant to the Merger Agreement, whereby each stock option outstanding as of immediately prior to the Effective Time fully vested and was cancelled at the Effective Time and converted into the right to receive a total amount in cash, equal to the product of (x) the excess, if any, of $37.00 over the exercise price per share of each stock option (without interest and subject to deduction for any required withholding taxes) and (y) the number of shares underlying such stock option. If the amount that could have been obtained upon the exercise of the stock option pursuant to the foregoing is equal to or less than zero, then the option was terminated without payment. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger, by and among DiaSorin S.p.A., Diagonal Subsidiary Inc. and Luminex Corporation (the "Issuer"), dated April 11, 2021 (the "Merger Agreement"), whereby each outstanding share of the Issuer's common stock was cancelled at the effective time (the "Effective Time") of the merger (the "Merger") and converted into the right to receive a cash payment of $37.00 per share.
F2: This balance includes 29 shares obtained under the Luminex Corporation Employee Stock Purchase Plan on May 31, 2021.
F3: Disposed of pursuant to the Merger Agreement, whereby unvested shares of restricted stock which were outstanding as of immediately prior to the Effective Time fully vested and became unrestricted common stock, and each such share of common stock that was outstanding immediately prior to the Effective Time was canceled at the Effective Time, in exchange for cash payments in the amount of $37.00 per share (without interest and subject to deduction for any required withholding taxes).
F4: Disposed of pursuant to the Merger Agreement, whereby each stock option outstanding as of immediately prior to the Effective Time fully vested and was cancelled at the Effective Time and converted into the right to receive a total amount in cash, equal to the product of (x) the excess, if any, of $37.00 over the exercise price per share of each stock option (without interest and subject to deduction for any required withholding taxes) and (y) the number of shares underlying such stock option. If the amount that could have been obtained upon the exercise of the stock option pursuant to the foregoing is equal to or less than zero, then the option was terminated without payment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2017 Filed Feb 28, 2017 12:38 UTC | LUMINEX CORP LMNX · Entity 137318 | GrantStock Option (Right To Buy) · Derivative | 18,771 | $0.00 Strike: $19.13 | $0.00 |
DisclosureSEC source: 0001033905-17-000024 · wf-form4_148830350930693.xml · derivative · entry 2 Bennett Todd C. · CIK 0001690473 · SVP, Global Sales & Cust Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,771 Underlying: Common Stock · 18,771 shares Expires 2023-03-22 F1 · date: On February 24, 2017, the Board of Directors of Luminex Corporation determined the level of performance and the number of shares earned for this performance option. The option will vest in four equal installments on the first, second, third and fourth anniversary of the 3/22/2016 grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.